References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Kubotaetal(2009)M-CSFinhibitionselectivelytargetspathologicalangiogenesisandlymphangiogenesis.J.Exp.Med.2061089PMID:19398755
Ohnoetal(2007)Theorally-activeandselectivec-FmstyrosinekinaseinhibitorKi20227inhibitsdiseaseprogressioninacollagen-inducedarthritismousemodel.Eur.J.Immunol.38283PMID:18085662
Ohnoetal(2006)Ac-fmstyrosinekinaseinhibitor,Ki20227,suppressesosteoclastdifferentiationandosteolyticbonedestructioninabonemetastasismodel.Mol.CancerTher.52634PMID:17121910
Keywords:Ki20227,supplier,Ki20227,c-Fms,macrophage,colony-stimulating,factor,receptors,M-CSFR,CSF1R,inhibitors,inhibits,osteolysis,osteoclasts,Other,RTKs,Other,RTKs,TocrisBioscience